| http://dbpedia.org/ontology/abstract
|
Ein MAP-Kinase-Inhibitor ist ein Hemmstoff des MAP-Kinase-Wegs und gehört als Tyrosinkinase-Inhibitor oder Serin/Threoninkinase-Inhibitor zu den Proteinkinaseinhibitoren.
, A MEK inhibitor is a chemical or drug that … A MEK inhibitor is a chemical or drug that inhibits the mitogen-activated protein kinase kinase enzymes MEK1 and/or MEK2.They can be used to affect the MAPK/ERK pathway which is often overactive in some cancers. (See MAPK/ERK pathway#Clinical significance.) Hence MEK inhibitors have potential for treatment of some cancers, especially BRAF-mutated melanoma, and KRAS/BRAF mutated colorectal cancer., and KRAS/BRAF mutated colorectal cancer.
|
| http://dbpedia.org/ontology/wikiPageID
|
37952149
|
| http://dbpedia.org/ontology/wikiPageLength
|
6599
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1032298751
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Non-small_cell_lung_cancer +
, http://dbpedia.org/resource/Multiple_myeloma +
, http://dbpedia.org/resource/XL518 +
, http://dbpedia.org/resource/Selumetinib +
, http://dbpedia.org/resource/Mitogen-activated_protein_kinase_kinase +
, http://dbpedia.org/resource/Binimetinib +
, http://dbpedia.org/resource/Colorectal_cancer +
, http://dbpedia.org/resource/Category:MEK_inhibitors +
, http://dbpedia.org/resource/Cobimetinib +
, http://dbpedia.org/resource/CI-1040 +
, http://dbpedia.org/resource/PD-325901 +
, http://dbpedia.org/resource/TAK-733 +
, http://dbpedia.org/resource/Vemurafenib +
, http://dbpedia.org/resource/Encorafenib +
, http://dbpedia.org/resource/Trametinib +
, http://dbpedia.org/resource/MEK2 +
, http://dbpedia.org/resource/Melanoma +
, http://dbpedia.org/resource/PD035901 +
, http://dbpedia.org/resource/MEK1 +
, http://dbpedia.org/resource/MAPK/ERK_pathway +
, http://dbpedia.org/resource/Dabrafenib +
, http://dbpedia.org/resource/BRAF_%28gene%29 +
, http://dbpedia.org/resource/KRAS_%28gene%29 +
, http://dbpedia.org/resource/Clinical_trial +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:MEK_inhibitors +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Chemical +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/MEK_inhibitor?oldid=1032298751&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/MEK_inhibitor +
|
| owl:sameAs |
https://global.dbpedia.org/id/gDBS +
, http://rdf.freebase.com/ns/m.0p8v7c6 +
, http://de.dbpedia.org/resource/MAP-Kinase-Inhibitor +
, http://www.wikidata.org/entity/Q17142288 +
, http://yago-knowledge.org/resource/MEK_inhibitor +
, http://dbpedia.org/resource/MEK_inhibitor +
|
| rdf:type |
http://dbpedia.org/class/yago/Substance100020090 +
, http://dbpedia.org/class/yago/Agent114778436 +
, http://dbpedia.org/class/yago/Drug103247620 +
, http://dbpedia.org/class/yago/Antineoplastic102722458 +
, http://dbpedia.org/ontology/ChemicalCompound +
, http://dbpedia.org/class/yago/CytotoxicDrug103157987 +
, http://dbpedia.org/class/yago/WikicatExperimentalCancerDrugs +
, http://dbpedia.org/class/yago/WikicatProteinKinaseInhibitors +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Inhibitor114724436 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/CausalAgent100007347 +
, http://dbpedia.org/class/yago/Medicine103740161 +
|
| rdfs:comment |
Ein MAP-Kinase-Inhibitor ist ein Hemmstoff des MAP-Kinase-Wegs und gehört als Tyrosinkinase-Inhibitor oder Serin/Threoninkinase-Inhibitor zu den Proteinkinaseinhibitoren.
, A MEK inhibitor is a chemical or drug that … A MEK inhibitor is a chemical or drug that inhibits the mitogen-activated protein kinase kinase enzymes MEK1 and/or MEK2.They can be used to affect the MAPK/ERK pathway which is often overactive in some cancers. (See MAPK/ERK pathway#Clinical significance.) Hence MEK inhibitors have potential for treatment of some cancers, especially BRAF-mutated melanoma, and KRAS/BRAF mutated colorectal cancer., and KRAS/BRAF mutated colorectal cancer.
|
| rdfs:label |
MEK inhibitor
, MAP-Kinase-Inhibitor
|
